Speech-Language Pathologists in New Lebanon, NY Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Ms. Vicki Jeanne Count, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1478 Route 20, Walter B Howard Elementary School, New Lebanon, NY 12125 Phone: 518-794-8554 |
News Archive
$28 million awarded to help establish new community health centers
The funds, provided by the Department of Health and Human Services as a result of the health law, will help an estimated 286,000 people gain access to health care, according to HHS officials.
Fear stops some parents vaccinating their children
A new study has found that the majority of parents who choose not to vaccinate their children do so out of fear that the vaccine will cause more harm than the disease it prevents.
FDA approves Gilead's Complera for treatment of HIV-1 infection
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Complera, a complete single-tablet regimen for the treatment of HIV-1 infection in treatment-naïve adults.
Decision Resources: 52% of surveyed cardiologists identify furosemide as efficacious acute heart failure therapy
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the highest proportion of surveyed cardiologists identify furosemide as the most efficacious agent for the treatment of acute heart failure when compared to other available therapies.
SynCon DNA vaccine shows advantages in magnitude and breadth of immune responses in non-human primates
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
› Verified 5 days ago